KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for National Health Investors (NHI) over the last 16 years, with Q3 2025 value amounting to $176.0 million.

  • National Health Investors' Short-Term Debt issuances rose 4193.55% to $176.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $710.7 million, marking a year-over-year increase of 11867.69%. This contributed to the annual value of $449.7 million for FY2024, which is 2354.4% up from last year.
  • Latest data reveals that National Health Investors reported Short-Term Debt issuances of $176.0 million as of Q3 2025, which was up 4193.55% from $68.0 million recorded in Q2 2025.
  • National Health Investors' Short-Term Debt issuances' 5-year high stood at $261.0 million during Q1 2025, with a 5-year trough of $10.0 million in Q2 2022.
  • Moreover, its 5-year median value for Short-Term Debt issuances was $64.5 million (2024), whereas its average is $91.0 million.
  • Per our database at Business Quant, National Health Investors' Short-Term Debt issuances tumbled by 7600.0% in 2021 and then surged by 34237.29% in 2025.
  • Over the past 5 years, National Health Investors' Short-Term Debt issuances (Quarter) stood at $35.0 million in 2021, then skyrocketed by 71.43% to $60.0 million in 2022, then surged by 35.0% to $81.0 million in 2023, then skyrocketed by 153.95% to $205.7 million in 2024, then dropped by 14.44% to $176.0 million in 2025.
  • Its last three reported values are $176.0 million in Q3 2025, $68.0 million for Q2 2025, and $261.0 million during Q1 2025.